Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04709419 · ClinicalTrials.gov registry record · NA
Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04709419 is a NA study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT04709419, a NA study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is a prospective, multicenter, double-blind, 1:1 randomized clinical trial. The purpose of this study is to demonstrate that the use of Celliant Socks increases tissue oxygenation (via oxygen saturation, StO2) and incidence of wound closure in subjects with diabetic foot ulcers. This study will use hyperspectral imaging and wound assessment to measure these outcomes. The study will enroll 254 evaluable subjects total, 127 per arm to meet the Primary Endpoint. Enrollment may continue up to twenty-five hundred (2500) evaluable subjects total to meet the Key Secondary Endpoint of complete wound closure.
Interventions
- DEVICE Celliant Diabetic Medical Socks
- DEVICE Control (placebo) Medical Socks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-07-28 |
| Est. Completion | 2023-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04709419
The ClinicalTrials.gov registry entry for NCT04709419 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Celliant Diabetic Medical Socks is the first listed.
NCT04709419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04709419 about?
NCT04709419 is a clinical study titled "Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds". This study is a prospective, multicenter, double-blind, 1:1 randomized clinical trial. The purpose of this study is to demonstrate that the use of Celliant Socks increases tissue oxygenation (via oxygen saturation, StO2) and incidence of wound closure in subjects with diabetic foot ulcers. This stud...
What is the current status of trial NCT04709419?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2022-07-28. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT04709419?
The interventions under investigation include: Celliant Diabetic Medical Socks (DEVICE), Control (placebo) Medical Socks (DEVICE).
Who is sponsoring clinical trial NCT04709419?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.